Kintara Therapeutics (KTRA) is Suspending Development of VAL-08
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Kintara Therapeutics Announces Preliminary Topline Results From GBM AGILE Study
October 31, 2023 8:00 AM EDT- VAL-083 Did Not Perform Better Than Current Standards of Care -
- Company Suspending Development of VAL-083, Shifting Focus to REM-001 Program and Other Strategic Opportunities -
SAN DIEGO, Oct. 31, 2023 /PRNewswire/ --... More



